Literature DB >> 15006594

Evaluation and treatment for angina in pulmonary arterial hypertension.

Robyn J Barst.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15006594     DOI： 10.1016/j.amjmed.2004.01.002

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  3 in total

1.  Effects of ranolazine on exercise capacity, right ventricular indices, and hemodynamic characteristics in pulmonary arterial hypertension: a pilot study.

Authors:  Sadiya S Khan; Michael J Cuttica; Lauren Beussink-Nelson; Anastasia Kozyleva; Cynthia Sanchez; Hamorabi Mkrdichian; Senthil Selvaraj; Jane E Dematte; Daniel C Lee; Sanjiv J Shah
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

2.  Australian perspective regarding recommendations for physical activity and exercise rehabilitation in pulmonary arterial hypertension.

Authors:  Robin Fowler; Sue Jenkins; Andrew Maiorana; Kevin Gain; Gerry O'Driscoll; Eli Gabbay
Journal:  J Multidiscip Healthc       Date:  2011-12-20

3.  Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double-blind placebo-controlled study.

Authors:  Dunbar Ivy; Damien Bonnet; Rolf M F Berger; Gisela M B Meyer; Simin Baygani; Baohui Li
Journal:  Pulm Circ       Date:  2021-06-23       Impact factor: 3.017
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.